epi-2021-0230 Suppl. Material

Supplementary Table 1. Overall sample information and patients’ characteristics. Supplementary Table 2. Primer sequences for qRT-PCR Supplementary Table 3. Four miRNAs expression level of UC patients and HCs in miRNA sequencing data Supplementary Figure 1 Correlation analysis of test samples. (A) CircRNAs data correlation analysis of test samples. (B) MiRNAs data correlation analysis of test samples. (C) MRNAs data correlation analysis of test samples. Supplementary Figure 2 Comparative analysis of hsa_circ_0001021 from UC patients treated with or without medicine. (A) Comparative analysis of hsa_circ_0001021 from UC patients treated with or without 5-ASA. (B) Comparative analysis of hsa_circ_0001021 from UC patients treated with or without steroids. NS, nonsignificant.